by Vandana Singh | Jan 20, 2026 | General
On Friday, Genmab A/S (NASDAQ:GMAB) released topline results from the Phase 3 EPCORE DLBCL-1 trial of epcoritamab for diffuse large B-cell lymphoma (DLBCL). The trial evaluated epcoritamab to the investigator’s choice of chemotherapy, either rituximab plus gemcitabine...
by Piero Cingari | Jan 20, 2026 | General
Wall Street tumbled on Tuesday, reopening after the Martin Luther King Jr. Day holiday, as risk-off sentiment intensified following President Donald Trump’s aggressive new trade stance toward Europe. The S&P 500 fell 1.5% to 6,840, eyeing its worst session...
by Vandana Singh | Jan 20, 2026 | General
On Sunday, Mesoblast Limited (NASDAQ:MESO) provided feedback received from the U.S. Food & Drug Administration (FDA) on potential filing of a Biologics License Application (BLA) for its allogeneic cell therapy product rexlemestrocel-L for chronic discogenic low...
by Parshwa Turakhiya | Jan 20, 2026 | General
CFTC chairman Michael S. Selig has launched a “Future-Proof” initiative to rewrite crypto regulations and end enforcement-based policymaking that drove U.S. companies offshore. CFTC Shifts From Lawsuits To Rule-Writing Selig on Tuesday announced the agency will stop...
by Chandrima Sanyal | Jan 20, 2026 | General
Harbor Capital Advisors has launched a new actively managed ETF aimed at tapping into what it sees as an improving outlook for U.S. small-cap growth stocks. • Harbor Active Small Cap Growth ETF shares are consolidating. What’s next for SGRW stock? The timing is...
Recent Comments